{"pmid":32293511,"title":"COVID-19 randomised trial protocols: rapid publication without barriers.","text":["COVID-19 randomised trial protocols: rapid publication without barriers.","Trials","Treweek, Shaun","Juni, Peter","Li, Tianjing","Collin, Jonathan","Briel, Matthias","Chan, An-Wen","Hemming, Karla","Meurer, William J","Sydes, Matthew R","Grimshaw, Jeremy M","32293511"],"journal":"Trials","authors":["Treweek, Shaun","Juni, Peter","Li, Tianjing","Collin, Jonathan","Briel, Matthias","Chan, An-Wen","Hemming, Karla","Meurer, William J","Sydes, Matthew R","Grimshaw, Jeremy M"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32293511","week":"202016|Apr 13 - Apr 19","doi":"10.1186/s13063-020-04304-3","keywords":["COVID-19"],"source":"PubMed","weight":0,"_version_":1664266295702454272,"score":8.233237,"similar":[{"pmid":32302395,"title":"Rapid Development of Telehealth Capabilities within Pediatric Patient Portal Infrastructure for COVID-19 Care: Barriers, Solutions, Results.","text":["Rapid Development of Telehealth Capabilities within Pediatric Patient Portal Infrastructure for COVID-19 Care: Barriers, Solutions, Results.","The COVID-19 national emergency has led to surging care demand and the need for unprecedented telehealth expansion. Rapid telehealth expansion can be especially complex for pediatric patients. From the experience of a large academic medical center, this report describes a pathway for efficiently increasing capacity of remote pediatric enrollment for telehealth while fulfilling privacy, security, and convenience concerns. The design and implementation of the process took two days. Weekly enrollment subsequently increased 10-fold for children (age 0-12 years) and 1.2-fold for adolescents (age 13-17 years). Weekly telehealth visits increased 200-fold for children and 90-fold for adolescents. The obstacles and solutions presented in this report can provide guidance to health systems for similar challenges during the COVID-19 response and future disasters.","J Am Med Inform Assoc","Patel, Pious D","Cobb, Jared","Wright, Deidre","Turer, Rob","Jordan, Tiffany","Humphrey, Amber","Kepner, Adrienne L","Smith, Gaye","Rosenbloom, S Trent","32302395"],"abstract":["The COVID-19 national emergency has led to surging care demand and the need for unprecedented telehealth expansion. Rapid telehealth expansion can be especially complex for pediatric patients. From the experience of a large academic medical center, this report describes a pathway for efficiently increasing capacity of remote pediatric enrollment for telehealth while fulfilling privacy, security, and convenience concerns. The design and implementation of the process took two days. Weekly enrollment subsequently increased 10-fold for children (age 0-12 years) and 1.2-fold for adolescents (age 13-17 years). Weekly telehealth visits increased 200-fold for children and 90-fold for adolescents. The obstacles and solutions presented in this report can provide guidance to health systems for similar challenges during the COVID-19 response and future disasters."],"journal":"J Am Med Inform Assoc","authors":["Patel, Pious D","Cobb, Jared","Wright, Deidre","Turer, Rob","Jordan, Tiffany","Humphrey, Amber","Kepner, Adrienne L","Smith, Gaye","Rosenbloom, S Trent"],"date":"2020-04-18T11:00:00Z","year":2020,"_id":"32302395","week":"202016|Apr 13 - Apr 19","doi":"10.1093/jamia/ocaa065","keywords":["covid-19","consumer health informatics","patient portals","policy","sars-cov-2","telehealth"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664357978707329024,"score":51.360523},{"pmid":32200994,"title":"High-flow nasal-oxygenation-assisted fibreoptic tracheal intubation in critically ill patients with COVID-19 pneumonia: a prospective randomised controlled trial.","text":["High-flow nasal-oxygenation-assisted fibreoptic tracheal intubation in critically ill patients with COVID-19 pneumonia: a prospective randomised controlled trial.","Br J Anaesth","Wu, Cai-Neng","Xia, Lin-Zhi","Li, Kun-Hong","Ma, Wu-Hua","Yu, Dong-Nan","Qu, Bo","Li, Bi-Xi","Cao, Ying","32200994"],"journal":"Br J Anaesth","authors":["Wu, Cai-Neng","Xia, Lin-Zhi","Li, Kun-Hong","Ma, Wu-Hua","Yu, Dong-Nan","Qu, Bo","Li, Bi-Xi","Cao, Ying"],"date":"2020-03-24T11:00:00Z","year":2020,"_id":"32200994","week":"202013|Mar 23 - Mar 29","doi":"10.1016/j.bja.2020.02.020","keywords":["COVID-19 pneumonia","airway management","high-flow nasal oxygenation","preoxygenation","tracheal intubation"],"source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1663352133669355523,"score":47.779213},{"pmid":32292826,"pmcid":"PMC7141164","title":"A living systematic review protocol for COVID-19 clinical trial registrations.","text":["A living systematic review protocol for COVID-19 clinical trial registrations.","Since the coronavirus disease 2019 (COVID-19) outbreak was identified in December 2019 in Wuhan, China, a strong response from the research community has been observed with the proliferation of independent clinical trials assessing diagnostic methods, therapeutic and prophylactic strategies. While there is no intervention for the prevention or treatment of COVID-19 with proven clinical efficacy to date, tools to distil the current research landscape by intervention, level of evidence and those studies likely powered to address future research questions is essential. This living systematic review aims to provide an open, accessible and frequently updated resource summarising the characteristics of COVID-19 clinical trial registrations. Weekly search updates of the WHO International Clinical Trials Registry Platform (ICTRP) and source registries will be conducted. Data extraction by two independent reviewers of trial characteristic variables including categorisation of trial design, geographic location, intervention type and targets, level of evidence and intervention adaptability to low resource settings will be completed. Descriptive and thematic synthesis will be conducted. A searchable and interactive visualisation of the results database will be created, and made openly available online. Weekly results from the continued search updates will be published and made available on the Infectious Diseases Data Observatory (IDDO) website ( COVID-19 website). This living systematic review will provide a useful resource of COVID-19 clinical trial registrations for researchers in a rapidly evolving context. In the future, this sustained review will allow prioritisation of research targets for individual patient data meta-analysis.","Wellcome Open Res","Maguire, Brittany J","Guerin, Philippe J","32292826"],"abstract":["Since the coronavirus disease 2019 (COVID-19) outbreak was identified in December 2019 in Wuhan, China, a strong response from the research community has been observed with the proliferation of independent clinical trials assessing diagnostic methods, therapeutic and prophylactic strategies. While there is no intervention for the prevention or treatment of COVID-19 with proven clinical efficacy to date, tools to distil the current research landscape by intervention, level of evidence and those studies likely powered to address future research questions is essential. This living systematic review aims to provide an open, accessible and frequently updated resource summarising the characteristics of COVID-19 clinical trial registrations. Weekly search updates of the WHO International Clinical Trials Registry Platform (ICTRP) and source registries will be conducted. Data extraction by two independent reviewers of trial characteristic variables including categorisation of trial design, geographic location, intervention type and targets, level of evidence and intervention adaptability to low resource settings will be completed. Descriptive and thematic synthesis will be conducted. A searchable and interactive visualisation of the results database will be created, and made openly available online. Weekly results from the continued search updates will be published and made available on the Infectious Diseases Data Observatory (IDDO) website ( COVID-19 website). This living systematic review will provide a useful resource of COVID-19 clinical trial registrations for researchers in a rapidly evolving context. In the future, this sustained review will allow prioritisation of research targets for individual patient data meta-analysis."],"journal":"Wellcome Open Res","authors":["Maguire, Brittany J","Guerin, Philippe J"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32292826","week":"202016|Apr 13 - Apr 19","doi":"10.12688/wellcomeopenres.15821.1","keywords":["COVID-19","Living systematic review","clinical trials","coronavirus","emerging infections"],"source":"PubMed","topics":["Treatment"],"weight":1,"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664266295784243201,"score":46.413414},{"pmid":32301757,"title":"Interpretations of \"Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7)\".","text":["Interpretations of \"Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7)\".","Chin Med J (Engl)","Zhao, Jing-Ya","Yan, Jia-Yang","Qu, Jie-Ming","32301757"],"journal":"Chin Med J (Engl)","authors":["Zhao, Jing-Ya","Yan, Jia-Yang","Qu, Jie-Ming"],"date":"2020-04-18T11:00:00Z","year":2020,"_id":"32301757","week":"202016|Apr 13 - Apr 19","doi":"10.1097/CM9.0000000000000866","source":"PubMed","topics":["Treatment","Diagnosis"],"weight":1,"_version_":1664357978590937088,"score":41.74073}]}